$GLUEMonte Rosa Therapeutics, Inc.

📅 Upcoming

🕒 Recent(90d)

News

• With $263M, LifeMine unearths a new drug for organ transplants
  Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplanted organs.
  biopharma_dive · 5d ago
• Novo’s late-stage IL-6 stumble shakes inflammation space
  Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s…
  biospace · 8d ago
• Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’
  The young venture firm, which has bet heavily on tech and biotech’s convergence, has now invested in 35 companies and recently saw one of them acquired by AI giant Anthropic.
  biopharma_dive · 21d ago
• STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
  After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
  stat · 1mo ago
• Covid vaccination cut risk of adverse heart events, large study finds
  Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.
  stat · 1mo ago
• STAT+: Lilly’s Ajax acquisition may have been worth it
  A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout
  stat · 1mo ago
• STAT+: Prometheus raises $12 billion in capital for artificial engineers
  Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
  stat · 2mo ago
• STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
  Hospital execs agree that affordability is a major issue. What to do about it is less clear.
  stat · 2mo ago
• STAT+: An obesity drug deep-dive, and peptides move mainstream
  Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…
  stat · 2mo ago
• Nonprofit buys experimental cancer drug to maintain patient access
  In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
  stat · 2mo ago